Only Certain Gynecologic Malignancies Benefit from Immunotherapy – Curetoday.com
|
Only Certain Gynecologic Malignancies Benefit from Immunotherapy
Curetoday.com As checkpoint inhibitors have changed the treatment landscape for many cancers, three specific biomarkers identified a subgroup of women with cervical and ovarian cancer tumor types who may benefit from such therapies. BY Kristie L. Kahl. PUBLISHED … |
